These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30079129)

  • 1. Ectopic expression of the osteogenic master gene
    Valenti MT; Dalle Carbonare L; Mottes M
    World J Stem Cells; 2018 Jul; 10(7):78-81. PubMed ID: 30079129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Insights into the Runt Domain of RUNX2 in Melanoma Cell Proliferation and Migration.
    Deiana M; Dalle Carbonare L; Serena M; Cheri S; Parolini F; Gandini A; Marchetto G; Innamorati G; Manfredi M; Marengo E; Brandi J; Cecconi D; Mori A; Mina MM; Antoniazzi F; Mottes M; Tiso N; Malerba G; Zipeto D; Valenti MT
    Cells; 2018 Nov; 7(11):. PubMed ID: 30463392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Runx2 expression: A mesenchymal stem marker for cancer.
    Valenti MT; Serafini P; Innamorati G; Gili A; Cheri S; Bassi C; Dalle Carbonare L
    Oncol Lett; 2016 Nov; 12(5):4167-4172. PubMed ID: 27895787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Signatures at the RUNX2-P1 and Sp7 Gene Promoters Control Osteogenic Lineage Commitment of Umbilical Cord-Derived Mesenchymal Stem Cells.
    Sepulveda H; Aguilar R; Prieto CP; Bustos F; Aedo S; Lattus J; van Zundert B; Palma V; Montecino M
    J Cell Physiol; 2017 Sep; 232(9):2519-2527. PubMed ID: 27689934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZBTB16 induces osteogenic differentiation marker genes in dental follicle cells independent from RUNX2.
    Felthaus O; Gosau M; Morsczeck C
    J Periodontol; 2014 May; 85(5):e144-51. PubMed ID: 24359167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Runx2 alleviates high glucose-suppressed osteogenic differentiation via PI3K/AKT/GSK3β/β-catenin pathway.
    Chen Y; Hu Y; Yang L; Zhou J; Tang Y; Zheng L; Qin P
    Cell Biol Int; 2017 Aug; 41(8):822-832. PubMed ID: 28462510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Runx2: a master organizer of gene transcription in developing and maturing osteoblasts.
    Schroeder TM; Jensen ED; Westendorf JJ
    Birth Defects Res C Embryo Today; 2005 Sep; 75(3):213-25. PubMed ID: 16187316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of genetic alterations in human endometrial cancer and melanoma: distinct tumorigenic pathways that share a frequent abnormal PI3K/AKT cascade.
    Ogawa K; Sun C; Horii A
    Oncol Rep; 2005 Dec; 14(6):1481-5. PubMed ID: 16273242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of bone sialoprotein (BSP) and the pivotal transcriptional regulator of osteogenesis, Cbfa1/Runx2, in malignant melanoma.
    Riminucci M; Corsi A; Peris K; Fisher LW; Chimenti S; Bianco P
    Calcif Tissue Int; 2003 Sep; 73(3):281-9. PubMed ID: 14667142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Htra1 is a Novel Transcriptional Target of RUNX2 That Promotes Osteogenic Differentiation.
    Iyyanar PPR; Thangaraj MP; Eames BF; Nazarali AJ
    Cell Physiol Biochem; 2019; 53(5):832-850. PubMed ID: 31703162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma.
    Boregowda RK; Medina DJ; Markert E; Bryan MA; Chen W; Chen S; Rabkin A; Vido MJ; Gunderson SI; Chekmareva M; Foran DJ; Lasfar A; Goydos JS; Cohen-Solal KA
    Oncotarget; 2016 May; 7(20):29689-707. PubMed ID: 27102439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor snail regulates osteogenic differentiation by repressing Runx2 expression.
    Park SJ; Jung SH; Jogeswar G; Ryoo HM; Yook JI; Choi HS; Rhee Y; Kim CH; Lim SK
    Bone; 2010 Jun; 46(6):1498-507. PubMed ID: 20215006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pax2 is essential for proliferation and osteogenic differentiation of mouse mesenchymal stem cells via Runx2.
    Lu M; Guo S; Hong F; Zhang Y; Yuan L; Ma C; Ma J
    Exp Cell Res; 2018 Oct; 371(2):342-352. PubMed ID: 30144446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hTERT transcription is repressed by Cbfa1 in human mesenchymal stem cell populations.
    Isenmann S; Cakouros D; Zannettino A; Shi S; Gronthos S
    J Bone Miner Res; 2007 Jun; 22(6):897-906. PubMed ID: 17352650
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Bai X; Kong Y; Chi Z; Sheng X; Cui C; Wang X; Mao L; Tang B; Li S; Lian B; Yan X; Zhou L; Dai J; Guo J; Si L
    Clin Cancer Res; 2017 Oct; 23(20):6120-6127. PubMed ID: 28720667
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypoxia and MITF regulate KIT oncogenic properties in melanocytes.
    Laugier F; Delyon J; André J; Bensussan A; Dumaz N
    Oncogene; 2016 Sep; 35(38):5070-7. PubMed ID: 26973244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small nuclear ribonucleoprotein polypeptide N (Sm51) promotes osteogenic differentiation of bone marrow mesenchymal stem cells by regulating Runx2.
    Meng F; Xu L; Huang S; Liu Y; Hou Y; Wang K; Jiang X; Li G
    Cell Tissue Res; 2016 Oct; 366(1):155-62. PubMed ID: 27184949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of RUNX2 transcription factor in epithelial mesenchymal transition in non-small cell lung cancer lung cancer: Epigenetic control of the RUNX2 P1 promoter.
    Herreño AM; Ramírez AC; Chaparro VP; Fernandez MJ; Cañas A; Morantes CF; Moreno OM; Brugés RE; Mejía JA; Bustos FJ; Montecino M; Rojas AP
    Tumour Biol; 2019 May; 41(5):1010428319851014. PubMed ID: 31109257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone.
    Pratap J; Lian JB; Javed A; Barnes GL; van Wijnen AJ; Stein JL; Stein GS
    Cancer Metastasis Rev; 2006 Dec; 25(4):589-600. PubMed ID: 17165130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Importance of MITF Signaling Pathway in the Regulation of Proliferation and Invasiveness of Malignant Melanoma].
    Urban P; Rabajdová M; Veliká B; Špaková I; Bolerázska B; Mareková M
    Klin Onkol; 2016; 29(5):347-350. PubMed ID: 27739313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.